Advertisement

Topics

US Orphan status for Almac’s ovarian cancer drug

07:02 EDT 5 Jul 2017 | PharmaTimes

In big news for Northern Ireland-headquartered drug discovery group Almac, US regulators have awarded orphan drug status to the firm’s experimental drug for ovarian cancer.

Original Article: US Orphan status for Almac’s ovarian cancer drug

NEXT ARTICLE

More From BioPortfolio on "US Orphan status for Almac’s ovarian cancer drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...